Risk stratifier for sudden cardiac death beyond the left ventricular ejection fraction in Chagas cardiomyopathy.
Roberto Coury PedrosaJoão Paulo do Vale MadeiroAlex C AlbertoGabriel A LimeiraBasílio de Bragança PereiraEmília Matos do NascimentoFernando Soares SchlindweinGullien André NgPublished in: Pacing and clinical electrophysiology : PACE (2023)
It is possible to use APDR dynamics as an adjuvant in the SCD risk assessment in a subgroup of patients with a high risk of SCD and a very low risk of non-CV death with high power of discrimination.
Keyphrases
- ejection fraction
- aortic stenosis
- risk assessment
- left ventricular
- heart failure
- early stage
- acute myocardial infarction
- transcatheter aortic valve replacement
- human health
- clinical trial
- randomized controlled trial
- coronary artery disease
- aortic valve
- climate change
- acute coronary syndrome
- left atrial
- phase iii
- cardiac resynchronization therapy
- trypanosoma cruzi